Status:
UNKNOWN
Adherence Toolkit for Managing Nonadherence to HIV Medications in Indonesia
Lead Sponsor:
University of Groningen
Collaborating Sponsors:
Universitas Airlangga
Conditions:
Adult
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this usability study and a cluster randomised controlled trial is to investigate the effectiveness of an adherence toolkit as a decision support tool to improve adherence to antiretroviral...
Detailed Description
Consistent adherence to antiretroviral therapy (ART) is important to maintain viral suppression and good quality of life among people living with HIV. However, maintaining a high level of ART adherenc...
Eligibility Criteria
Inclusion
- Doctors, nurses, and pharmacists who have been trained to provide HIV care and treatment by the Indonesian Ministry of Health
- People living with HIV who have been receiving any ART regimens for at least six months, aged 18 years and older, with any coinfection or comorbidity, suspected to be nonadherent to HIV medications (e.g., having sustained treatment interruptions, inconsistent prescription refill, increased viral load \>1,000 copies/ml, decreased CD4 count \<200 cells/mm3, or developed opportunistic infections), and provided informed consent
Exclusion
- People who have severe mental or physical constraints, drop-out or withdraw after the commencement of the trial
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05996081
Start Date
January 2 2024
End Date
December 31 2025
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HIV clinics
Surabaya, Indonesia